4 results on '"Tetsuaki Sano"'
Search Results
2. Clinical efficacy of all-trans retinoic acid for treating adult T cell leukemia
- Author
-
Chikara Hirase, Yasuyoshi Morita, Yasuhiro Maeda, Shunsuke Takai, Yoichi Tatsumi, Jun-ichi Miyatake, Akihisa Kanamaru, Tetsuaki Sano, Terufumi Yamaguchi, Miyako Tanaka, and Yasuki Hijikata
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Pathology ,medicine.drug_class ,T-cell leukemia ,Retinoic acid ,Antineoplastic Agents ,Tretinoin ,Biology ,Gastroenterology ,chemistry.chemical_compound ,immune system diseases ,hemic and lymphatic diseases ,Internal medicine ,medicine ,Humans ,Leukemia-Lymphoma, Adult T-Cell ,Retinoid ,Aged ,Hematology ,Cancer ,General Medicine ,Middle Aged ,medicine.disease ,Leukemia ,Oncology ,chemistry ,Female ,Progressive disease ,medicine.drug - Abstract
We previously reported that all-trans retinoic acid (ATRA) inhibited growth in human T-cell leukemia virus type I (HTLV-I)-positive T-cell lines and in fresh cells from patients with adult T cell leukemia (ATL). Here, we confirmed the clinical effects of ATRA in 20 patients with ATL. The 20 patients (n = 20) with a median age of 56 (range 35–73) years who were diagnosed with ATL received ATRA orally. The efficacy of treatment was as follows: no complete response (CR), a partial response (PR) in 40% of the patients, no change (NC) in 45% of the patients, and a progressive disease (PD) in 15% of the patients. In seven acute-type ATL patients, a PR was achieved in two (28.5%), NC was observed in two (28.5%), and a PD was observed in three (42.8%). In three lymphoma-type ATL patients, a PR (100%) was achieved. Among four chronic-type ATL patients, a PR was achieved in one (25%) and NC was observed in the remaining three (75%). In six smoldering-type ATL patients, a PR was achieved in two (33.3%) and NC was observed in four (66.6%). The major side effects were headache (n = 5), transient liver dysfunction (n = 2), hyperlipidemia (n = 2), and anorexia (n = 1). These results indicated that ATRA might be a useful agent for the safe treatment of ATL.
- Published
- 2007
3. Deformation Behavior of Intrusion Bending for Steel Pipes
- Author
-
Hisashi Naoi and Tetsuaki Sano
- Subjects
Materials science ,media_common.quotation_subject ,Bend radius ,Bending ,Strength of materials ,Cylinder (engine) ,law.invention ,Intrusion ,law ,Ovality ,Eccentricity (behavior) ,Deformation (engineering) ,Composite material ,media_common - Abstract
We have investigated the intrusion bending for steel pipes for several years. The bending machine consists of three parts. They are called pusher, guide cylinder and gyro. The aim of this investigation is to reveal the effect of size and strength of materials, pushing forces and so on. That we study in this report are as follows: (1) The effect of bending radius ratio on ovality of outer diameter and eccentricity of wall thickness, and (2) the effect of ratio of wall thickness to outer diameter on ovality of outer diameter and eccentricity of wall thickness. The conclusions of this study are summarized as follows. (1) The ovality of outer diameter and the eccentricity of wall thickness increase as the bending radius ratio decreases. (2) The ovality of outer diameter decreases and the eccentricity of wall thickness increase as thickness outside diameter ratio increases.
- Published
- 2003
- Full Text
- View/download PDF
4. Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation
- Author
-
Takahiro Shimada, Kazunobu Kawanishi, Tetsuaki Sano, Masaki Higashishiba, Yoichi Tatsumi, Takashi Ashida, Jun-ichi Miyatake, Hajime Miyazato, Yoshiyasu Sumimoto, and Akihisa Kanamaru
- Subjects
Adult ,Lung Diseases ,Male ,medicine.medical_specialty ,Pathology ,Adolescent ,Enzyme-Linked Immunosorbent Assay ,Gastroenterology ,Sepsis ,Antigens, Neoplasm ,Internal medicine ,medicine ,Humans ,Transplantation, Homologous ,Antigens ,Bone Marrow Transplantation ,Glycoproteins ,medicine.diagnostic_test ,business.industry ,Respiratory disease ,Mucin-1 ,Mucins ,Hematology ,Middle Aged ,medicine.disease ,Transplantation ,Bronchoalveolar lavage ,medicine.anatomical_structure ,Respiratory failure ,Hematologic Neoplasms ,Female ,Bone marrow ,business ,Complication ,Lung Diseases, Interstitial ,Biomarkers ,Hemorrhagic cystitis - Abstract
KL-6, a mucinous high—molecular weight glycoprotein expressed on type 2 pneumocytes, has been shown to be elevated in the serum and bronchoalveolar lavage fluid of patients with interstitial pneumonitis (IP). We measured the serum levels of KL-6 in patients after they had undergone allogeneic bone marrow transplantation (BMT) to determine whether KL-6 could be a clinically useful indicator for the development of IP. The serum concentrations of KL-6 were determined by a sandwichtype enzyme-linked immunosorbent assay using an anti—KL-6 monoclonal antibody. A total of 1028 samples were tested from 76 patients (78 transplantations) who received BMTs. The KL-6 values were markedly elevated in patients with pulmonary complications, but not in those with acute and chronic graft-versus-host disease, hemorrhagic cystitis, herpes encephalitis, sepsis, and veno-occlusive disease.The serum levels of KL-6 from patients with pulmonary complications were significantly higher than from those without pulmonary complications (P < .001) and those with other complications (P < .001). Of the 12 patients with pulmonary complications, 6 had idiopathic IP (IIP). The levels were not high at the onset of IIP. Four of 6 IIP patients showed marked elevations of KL-6 levels in parallel with the severity of IP and died of respiratory failure without response to treatment.Assessment of serum KL-6 levels might not be useful for the early diagnosis of IP, but may be a useful indicator for monitoring the severity of IP after BMT.
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.